Bonterra's 10% second-lien notes and record production levels enhance its financial outlook, offering upside potential at a 0 ...

Renault's financial performance and growth prospects have deteriorated, with revenue and net income well below previous highs ...

Chevron (NYSE:CVX) is seeking non-binding bids for the sale of its 50% stake in Singapore Refining Company, in a deal that ...

Novo Nordisk (NVO) has released full data from a Phase 1b/2a trial for its novel obesity drug, amycretin noting that the injectable, designed to target GLP-1 and amylin receptors, caused up to 24% of ...